Save the Date April 3-4, 2014

Transcription

1 Save the Date April 3-4, 2014 Management Issues in the Life Science Industry with Eric Le Royer, Fredrik Ragmark and many more interesting speakers

2 Prepared and Supported by Smerud Medical Research International AS Drammensveien 41, N-0271 Oslo, NORWAY Tel Fax SMERUD is a leading contract research organization (CRO) with headquarters in Norway and whollyowned subsidiary companies across Europe. SMERUD consultants are specialists on managing clinical development programs for smaller biotech companies, especially focused on obtaining public and private co-funding grants, and conducting clinical phase 2a and 2b as well as smaller phase 3 trials in the most cost-efficient way. Lorange Institute of Business Zurich Hirsackerstrasse 46, CH-8810 Horgen, SWITZERLAND Tel Fax info@lorange.org Table of Content 1. Content Learning Outcomes Length & Credits Module Structure Costs Organization... 6 Lorange Institute of Business Zurich, January

3 1. Content One of the fastest growing industries today, the Life Sciences, comprise the fields of science that address issues relating to living organisms. In industry terms, this relates mainly to the fields of Pharmaceuticals, Medical Technology and Biotechnology, the focus of this module. Advancements in this industry are providing the basis to tackle major human diseases, such as cancer, neurodegeneration, cardiovascular, metabolic, infectious and inflammatory diseases, to name but a few. This industry is evolving continuously through increased understanding of biology (genetics and biochemistry) and of pathogenesis of disease, as well as through the development of new technology platforms. These changes have led to a re-configuration of the value chain of the sector with Biotechnology and Medical Technology becoming the main research engines and innovators of the Industry. Recent innovations present interesting opportunities: Increased knowledge of biochemical pathways leading to broader range of product types from small molecules to biologics Better diagnostic tools and identification of new biomarkers for better defined patient groups (even personalized medicine) and clearer understanding of disease Novel technology platforms for developing, assessing, approving and monitoring the effects / tolerability of drugs But, they have been accompanied by increasing challenges: Stricter regulatory environments with regional variance, including price regulation and cost awareness Greater public scrutiny impacting the ability to manage risk and compliance Scarcity of private funds for early stage ventures Challenges in retaining value through partnering with big Pharma / MedTech Declined R&D productivity of big Pharma As a result of this rapidly changing landscape, management is continuously faced with the need to adapt and respond to opportunities and challenges. This module is designed to give participants an overview of the industry, the key issues faced by management as well as the basic tools to address them. The participants will be given the opportunity to test out business ideas with peers and experts, a dynamic process with a concrete take-home message: from test-tube to IPO - what is the best way to get there? Lorange Institute of Business Zurich, January

4 The module is structured as follows: Systematic Overview of the Life Science Industry including Biotech, Pharmaceuticals, Medical devices, diagnostics etc. The first part of the module will consist of defining the space, an analysis of macro trends and industry trends as well as a detailed account of the value chain, i.e., taking a concept from lab to market Product Project Management in the Life Science Industry The second part of the module deals with critical issues in managing product projects and explores successful business approaches to product development, regulatory issues, intellectual property rights (IPR), risk mitigation, marketing and sales etc. Best Practices in Business Planning in the Life Science Industry The third and last part of the module will relate to opportunities and challenges in management incl. thorough business planning, financing and company life cycle management. Real-life cases shall be discussed and participants are encouraged to bring living cases for group discussions and review by experts 2. Learning Outcomes After this module, the participants will be able to: think and act productively about entrepreneurship, business models, regulatory processes in the context of life science industry. test and/or practice fresh and more effective approaches to product development and management, as well as to their leadership skills. communicate more effectively and reflect on the usefulness of theories (mental models), tools and approaches to project management and business planning. understand and influence dynamics and complexity of life sciences, as well as the roles financing, risk management and marketing play for the success. I have the privilege to work in life sciences for more than 25 years and to modestly be part of teams bringing innovations which impacted lives of many. More than in any place, this is a people business. Building stronger leaders through quality learning experiences strengthens our industry and boosts development opportunities to deliver better solutions to patients" Eric Le Royer, Co-founder Endosense Lorange Institute of Business Zurich, January

5 3. Length & Credits Participants deal with certain issues several times during the module. Prior to the module, participants shall work through designated literature and answer test questions in relation to the respective theory and their work. This guarantees that all participants start the module with the same knowledge base. Then they deal with the content during the workshop. Preparation: 2 months On-campus: 2 days Post-processing: 1 week (tentative) Credits: 4 ECTS credits (tentative) Assessment: Management Issues in the Life Science Industry 40% Pre-test 20% Participation 40% Post Assignment 4 ECTS Credits 4. Module Structure Thursday :30-09:30 Welcome & introduction. (Presentation of participants) 09:45-12:00 Industry background Structure, segments, macro trends, industry trends Definitions The Value Chain IP rights Lunch 13:00 15:00 Product Development & Regulatory Affairs Drug development oversight Medical device development oversight Regulatory strategy Target Product Profile Clinical Development Plan 15:15-17:30 Marketing & Sales Marketing strategy Dinner Friday :30-10:30 The Business Plan & Financing The life science business plan structure Funding: public vs private, timing etc. Strategic partnering Risk management 10:45 12:00 The Company Life Cycle Business models Organization Boards and advisors Exit options Peter Lorange / Knut Smerud Heiko Visarius, President VISARTIS Healthcare GmbH Knut Smerud Fredrik Ragmark, President Medicover (tentative) Masha Strømme Claus Møller, CEO Azanta (tentative) Lunch break 13:00 14:00 Industry Key Note Speaker: Eric Le Royer, Co-founder Endosense How was my initial business plan, and what did we do? 14:15 16:30 Meet the Professors parallel workshops on company All lecturers cases Biotech/Pharma sector Bring your own case! MedTech/Diagnostics sector 16:45 17:30 Wrap-up Knut Smerud Lorange Institute of Business Zurich, January

6 5. Costs The price for this module is CHF 3,500.- per participant and includes the organization, administration, teaching material as well as coffee breaks, lunch and bottled water. Insurance, ttransportation, accommodation (we recommend the 4 star plus Hotel Meierhof in Horgen ( 10 minutes walking distance from Lorange Campus) and dinner are not included in the price above. We have our own restaurant Imperiale on site. Take additional advantage of the early registration fee and register before February 1, 2014 for CHF 3,000.- For group registrations (3 persons and more), please contact the Lorange Institute at info@lorange.org for special conditions. 6. Organization The Business School of the Future Offers Key Insights! The Lorange Institute of Business Zurich is a business school of the future. We are very diverse and offer you flexibility with less administrative red tape. Our professors are global experts in their fields. They typically come from other academic institutions for short teaching stints at our business school, bringing with them the latest insights in the fields of management and business. Our educational methods are different: Rather than listening to a monologue, you will participate in thematic discussions with the professors, for our business school is a meeting place! You will network with fellow participants as well as faculty members establishing valuable contacts for life. We have a vision of a new way of learning tailored to the real needs of the 21st century. Learning which is eclectic and suits your personal needs and can be pursued while you work in your current position. What you learn at the Lorange Institute you can immediately put into practice on the job. We broaden your view of business challenges and solutions and present the latest in practice and theory. And we challenge you to discover your limits. Our programs are not just programs. They are innovative learning experiences that will change the way you look at business challenges and think about the values which lie beyond the balance sheet. Although we are at the forefront of academics, we are not locked away in an ivory tower. We are practical and pragmatic. At Lorange, you will solve current, real-life problems relating to leading companies. Change the way you act as a leader and fulfill your potential with a degree from the Lorange Institute of Business. Lorange Institute of Business Zurich, January